Announcement • May 02
Ianthus Capital Holdings, Inc. Announces CFO Changes, Effective April 29, 2026 iAnthus Capital Holdings, Inc. announced the appointment of Jason Ware as Chief Financial Officer, effective April 29, 2026. Jason brings more than twenty years of finance leadership experience across public companies and high-growth consumer brands, including Genesco, Nutrafol, Victoria’s Secret and L Brands, with deep expertise in financial planning and analysis, capital allocation, strategic planning, and investor relations. Immediately prior to the appointment of Jason as Chief Financial Officer, Justin Vu resigned as Chief Financial Officer of the Company as well as all positions with the Company’s subsidiaries and affiliates. Mr. Vu has served as the Company’s Chief Financial Officer since January 6, 2025, previously serving as the Company’s Interim Chief Financial Officer since April 5, 2024 and Senior Vice President of Finance since early 2023. Mr. Vu will continue to serve the Company in a consulting role for a period of up to six weeks following Mr. Vu’s resignation. Announcement • Apr 08
iAnthus Capital Holdings, Inc., Annual General Meeting, Jun 25, 2026 iAnthus Capital Holdings, Inc., Annual General Meeting, Jun 25, 2026. Announcement • May 01
iAnthus Capital Holdings, Inc., Annual General Meeting, Jun 26, 2025 iAnthus Capital Holdings, Inc., Annual General Meeting, Jun 26, 2025. Announcement • Jan 06
iAnthus Capital Holdings, Inc. Appoints Justin Vu as Chief Financial Officer iAnthus Capital Holdings, Inc. announced the appointment of Justin Vu as the permanent Chief Financial Officer of the Company, effective immediately. Mr. Vu was appointed to serve as Interim Chief Financial Officer on April 5, 2024 after joining iAnthus in early 2023 as Senior Vice President of Finance. Prior to joining iAnthus, Mr. Vu was a financial consultant and worked in various senior finance and accounting roles with a large US-based media and entertainment company. Announcement • Dec 30
iAnthus Capital Holdings, Inc. (CNSX:IAN) agreed to acquire Lifestyle Vape Inc. from Cheetah Ventures, Inc for $1.5 million. iAnthus Capital Holdings, Inc. (CNSX:IAN) agreed to acquire Lifestyle Vape Inc. from Cheetah Ventures, Inc for $1.5 million on December 30, 2024. The consideration consists of common equity of iAnthus Capital Holdings, Inc. to be issued for common equity of Lifestyle Vape Inc. iAnthus Capital Holdings, Inc. will pay an earnout/contingent payment cash. As part of the Acquisition, Michael Piermont, Co-Founder and CEO of Cheetah, will join iAnthus as Chief Commercial Officer. The transaction is subject to approval by regulatory board / committee. Announcement • May 01
iAnthus Capital Holdings, Inc., Annual General Meeting, Jun 27, 2024 iAnthus Capital Holdings, Inc., Annual General Meeting, Jun 27, 2024. Announcement • Mar 13
iAnthus Capital Holdings, Inc Announces Resignation of John Paterson from its Board of Directors iAnthus Capital Holdings, Inc. announced the resignation of John Paterson from its Board of Directors (the "Board"), effective immediately. Announcement • Dec 23
iAnthus Capital Holdings, Inc. Provides Update to Litigation Claim iAnthus Capital Holdings, Inc. provided an update to its news release dated June 3, 2020 disclosing the complaint filed by Hi-Med LLC ("Hi-Med"), the former holder of an unsecured debenture of the Company in the principal amount of USD 5 million (the "Unsecured Debenture"), in the U.S. District Court for the Southern District of New York. Hi-Med sought damages and other remedies against iAnthus for, among other things, alleged breaches of the Unsecured Debenture and the related Debenture Purchase Agreement. Effective on December 12, 2023, iAnthus and Hi-Med settled the litigation pursuant to a settlement agreement on terms that provide for, among other things, the issuance of 20,000,000 shares of the Company's common stock, no par value per share (the "Shares") to Hi-Med. Further to the settlement agreement, applicable filings are to be made in the U.S. district Court for the Southern District ofNew York to dismiss Hi-Med's claim with prejudice. The settlement agreement contains no admission of wrongdoing by the Company or any of its current or former directors and officers, nor are the Company or any of its currently or former directors and officers acknowledging any liability, wrongdoing or breaches of contract by entering into the settlement agreement. The Shares will be issued pursuant to a prospectus and registration exemption under Canadian securities law and will be subject to a Canadian holding period expiring four months and a day from the date of issuance. The Shares have not been, nor will they be, registered under the United States Securities Act of 1933 (the "Act"), as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration under the Act or an applicable exemption from the registration requirements thereof. Announcement • Dec 20
Ianthus Capital Holdings Inc. Announces Securities Class Action Settlement iAnthus Capital Holdings Inc. ("iAnthus") during the period from May 14, 2018 to and including April 5, 2020, and who held some or all of those securities at the close of trading on April 5, 2020 (defined as the "Class"). In 2020, a proposed securities class action was commenced against iAnthus and two of its former officers in the Ontario Superior Court of Justice (the "Court"). It is alleged that during the period from May 14, 2018 to and including April 5, 2020 (the "Class Period"), the Defendants made misrepresentations or omissions regarding iAnthus (whether contained in a public document or in an oral statement), or permitted or acquiesced in such misrepresentation(s) and/or omission(s). The parties have reached a proposed settlement of the class action, which is subject to approval by the Court (the "Agreement"). The Defendants do not admit any wrongdoing or liability. The Agreement is a compromise of disputed claims. This Notice provides a summary of the proposed settlement. Under the Agreement, the Defendants will pay or cause to be paid CAD 500,000 (the "Settlement Amount") in full and final settlement of all claims against them, including Class Counsel's fees and disbursements, any approved honorarium, administrative expenses, applicable taxes and interest, in exchange for a full release and a dismissal of the class action. The Settlement Amount, less approved Class Counsel's fees and disbursements, any approved honorarium, administration expenses (such administrative expenses estimated to be CAD 105,055 plus HST), taxes and interest will be distributed to the Class on a pro rata share in accordance with the Court-approved Plan of Allocation. It is estimated that the balance of the Settlement Amount that will be available to be distributed to the Class will be approximately CAD 200,000, inclusive of interest earned upon the Settlement Amount less taxes applicable to said interest. There will be a hearing (the "Approval Hearing") in which Class Counsel will request the Court to approve (i) the Agreement; (ii) their legal fees and expenses; and (iii) an honorarium for the representative Plaintiff in the amount of CAD 15,000. The Approval Hearing shall take place on February 20, 2024 via Zoom video-conferencing. At the Approval Hearing, the Court will determine whether the Agreement is fair, reasonable, and in the best interests of the Class. At the Approval Hearing, Class Counsel will seek Court approval of their request for fees equal to 30% of the Settlement Amount (being CAD 150,000 plus HST) plus reimbursement of their relevant expenses (estimated to be approximately CAD 1,000). Class Counsel has been working under a contingency-fee agreement, has not been paid as the matter has proceeded. Class Counsel will be requesting that their legal fees and disbursements be deducted from the Settlement Amount. Announcement • Oct 19
iAnthus Capital Holdings, Inc. Announces Launch of Edible Brand MOODZ iAnthus Capital Holdings, Inc. announced the expansion of its brand portfolio with the launch of its new edibles brand, MOODZ. The first MOODZ product will be gummies produced using a solventless process in accordance with the Company's best in class standards for purity and quality. The Company's solventless extraction products are produced as full spectrum, no chemical products that utilize the cannabis plant, water, ice and pressure. Starting October 18, 2023, Florida medical patients can experience MOODZ gummies across all Grow Healthy locations – where the natural qualities of the plant meets innovative excellence. Announcement • Oct 13
Ianthus Capital Holdings, Inc. Announces Resignation of Robert Galvin as Interim Chief Operating Officer iAnthus Capital Holdings, Inc. announces that Robert Galvin will transition out of his role as Interim Chief Operating Officer of the Company, effective immediately. Mr. Galvin joined the Company as Senior Vice President and Chief Administrative Officer in 2019 and served the Company in many roles, before being named Interim Chief Operating Officer on November 27, 2020, and has served in that role since that time. Announcement • Sep 12
iAnthus Capital Holdings, Inc., Annual General Meeting, Nov 09, 2023 iAnthus Capital Holdings, Inc., Annual General Meeting, Nov 09, 2023. 
